Effect of Endoscopic Papillary Large Balloon Dilation on Recurrent Rate of Patients With Recurrentstones in Bile Duct
Launched by AIR FORCE MILITARY MEDICAL UNIVERSITY, CHINA · Jan 2, 2015
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18-80
- • 2. Patients with recurrent CBDS after ERCP
- Exclusion Criteria:
- • 1. Benign or malignant CBD stricture
- • 2. Recurrent stone within 3 months after ERCP
- • 3. Previous endoscopic papillary large balloon dilation (EPLBD)
- • 4. Prior surgery of Bismuth II and Roux-en-Y
- • 5. Septic shock
- • 6. Coagulopathy (INR\>1.3), platelet\<50000 or using anti-coagulation drugs
- • 7. With expected life span less than 24 months
- • 8. Pregnant women
- • 9. Refusal or unable to give written informed consent
About Air Force Military Medical University, China
The Air Force Military Medical University (AFMMU) in China is a prestigious institution dedicated to advancing military medicine and healthcare research. With a strong emphasis on clinical trials and innovative medical practices, AFMMU integrates cutting-edge scientific research with practical applications to enhance the health and well-being of military personnel and the broader community. The university fosters collaboration among various disciplines, promoting a robust environment for training healthcare professionals and conducting impactful studies that address critical health challenges. Through its commitment to excellence and rigorous scientific methodology, AFMMU plays a pivotal role in shaping the future of military and civilian healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Xi'an, Shaanxi, China
Patients applied
Trial Officials
Yanglin Pan, MD
Principal Investigator
Xijing Hospital of Digestive Diseases.The Fourth Military Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials